|
1
|
BB Biotech
Schaffhausen,
Switzerland
|
$146M
|
+$4.59M
|
+100,000
|
+3%
|
|
|
2
|
Meditor Group
Hamilton,
Bermuda
|
$117M
|
–
|
–
|
–
|
|
|
3
|
Pentwater Capital Management
Naples,
Florida
|
$104M
|
-$5.16M
|
-112,500
|
-5%
|
|
|
4
|
PFM Health Sciences
San Francisco,
California
|
$87.4M
|
-$22.5M
|
-490,023
|
-20%
|
|
|
5
|
|
$83.4M
|
+$3.38M
|
+73,673
|
+4%
|
|
|
6
|
State Street
Boston,
Massachusetts
|
$81.9M
|
-$15.1M
|
-327,929
|
-15%
|
|
|
7
|
Vanguard Group
Malvern,
Pennsylvania
|
$73.2M
|
+$4.59M
|
+99,946
|
+6%
|
|
|
8
|
Boxer Capital
San Diego,
California
|
$61M
|
–
|
–
|
–
|
|
|
9
|
Aviva Holdings
New Providence,
Bahamas
|
$53.2M
|
–
|
–
|
–
|
|
|
10
|
Credit Suisse
Zurich,
Switzerland
|
$43.1M
|
-$5.65M
|
-123,053
|
-11%
|
|
|
11
|
Northern Trust
Chicago,
Illinois
|
$27.8M
|
+$1.68M
|
+36,535
|
+6%
|
|
|
12
|
Wasatch Advisors
Salt Lake City,
Utah
|
$24.7M
|
+$747K
|
+16,273
|
+3%
|
|
|
13
|
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
$22.9M
|
+$8.03M
|
+175,010
|
+51%
|
|
|
14
|
Fidelity Investments
Boston,
Massachusetts
|
$22.8M
|
-$18.8M
|
-408,895
|
-44%
|
|
|
15
|
Point72 Asset Management
Stamford,
Connecticut
|
$22.5M
|
+$6.57M
|
+143,200
|
+39%
|
|
|
16
|
Pictet Asset Management (UK)
London,
United Kingdom
|
$17.4M
|
+$2.14M
|
+46,642
|
+13%
|
|
|
17
|
Bellevue Group
Kuesnacht,
Switzerland
|
$17.4M
|
+$3.6M
|
+78,332
|
+25%
|
|
|
18
|
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
$15.7M
|
-$2.41M
|
-52,400
|
-13%
|
|
|
19
|
Amundi Asset Management US
Boston,
Massachusetts
|
$15.2M
|
+$1.03M
|
+22,479
|
+7%
|
|
|
20
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$13.4M
|
+$6.11K
|
+133
|
+0%
|
|
|
21
|
Nomura Holdings
Tokyo,
Japan
|
$12.7M
|
+$1.38M
|
+30,000
|
+12%
|
|
|
22
|
Geode Capital Management
Boston,
Massachusetts
|
$11.3M
|
+$1.85M
|
+40,382
|
+19%
|
|
|
23
|
|
$10.4M
|
+$918K
|
+20,005
|
+9%
|
|
|
24
|
Pinnacle Associates
New York
|
$8.52M
|
-$1.47M
|
-31,977
|
-14%
|
|
|
25
|
Tekla Capital Management
Boston,
Massachusetts
|
$8.4M
|
–
|
–
|
–
|
|
